Catalyst Wire Dossier Catalyst Wire Dossier

3,4-DAP

3,4-diaminopyridine
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 3,4-DAP, covering 2011-02-21 to 2013-07-18. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP

See pricing